[Technology of producing p-toluene isocyanate (C6H4CH3NCO) and a human albumin complex for clinical purposes].
Sieradzki
E
E
Wichtowski
W
W
Dziedziczko
A
A
D000906:Antibodies / Q000032:analysis; D003485:Cyanates / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D006801:Humans; D017953:Isocyanates; D012709:Serum Albumin; D014051:Toluene 2,4-Diisocyanate / Q000009:adverse effects* / Q000276:immunology
D000906:Antibodies; D003485:Cyanates; D017953:Isocyanates; D012709:Serum Albumin; D014051:Toluene 2,4-Diisocyanate; C025637:4-tolyl isocyanate
Technologia wytwarzania kompleksu izocyjanianu p-toluenu (C6H4CH3NCO) Z albumina ludzka dla celów klinicznych.